Tags

Type your tag names separated by a space and hit enter

[Dyspnea and normal systolic function].

Abstract

30-50% of patients presenting with symptoms of congestive heart failure exhibit a near normal left ventricular systolic function at rest, and an impaired diastolic function of the heart may be causative. Despite a better prognosis than in systolic heart failure, frequency of hospitalizations due to diastolic heart failure is comparable with systolic heart failure. According to the criteria of Vasan and Levy diagnosis of diastolic heart failure is probable, if symptoms and signs of heart failure are accompanied in proximity (within 72 h) by objective evidence of normal left ventricular systolic function. Newer echocardiographic techniques (e. g., tissue Doppler) aid to confirm the diagnosis and to determine the severity of dysfunction and may substitute invasive demonstration of impaired left ventricular relaxation, filling, compliance or stiffness for standardized diagnosis. Incorporation of biochemical test (BNP [brain natriuretic peptide]) allows differential diagnosis and may increase the accuracy of diagnosis. Due to inconsistent diagnostic criteria, data from prospective randomized controlled trials for the treatment of diastolic heart failure are rare. Basic principles include treatment of the underlying disease, i. e., control of hypertension, diabetes, or obstructive airway disease. Angiotensin 1 antagonists (ARB) have proven effective in regression of left ventricular hypertrophy (LIFE) and may reduce morbidity, but not mortality (CHARM). Maintenance of sinus rhythm, heart rate control (beta-blockers, calcium channel blockers) and anti-ischemic therapy may be indicated in view of pathophysiological aspects. Diuretics should be administered with caution in patients with symptoms of congestion, digitalis is not useful in the treatment of isolated diastolic heart failure. The results of ongoing trials (e. g., I-Preserve) may offer new therapeutic options, and evidence-based guidelines for the so far often unsatisfactory treatment of diastolic dysfunction/heart failure are awaited.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Abteilung Kardiologie und Pneumologie, Universität Göttingen, Göttingen.

    ,

    Source

    Herz 29:6 2004 Sep pg 602-8

    MeSH

    Diagnosis, Differential
    Dyspnea
    Heart Failure
    Humans
    Practice Guidelines as Topic
    Practice Patterns, Physicians'
    Prognosis
    Risk Assessment
    Risk Factors
    Stroke Volume
    Systole
    Ventricular Function, Left

    Pub Type(s)

    English Abstract
    Journal Article

    Language

    ger

    PubMed ID

    15912435

    Citation

    Hasenfuss, Gerd, et al. "[Dyspnea and Normal Systolic Function]." Herz, vol. 29, no. 6, 2004, pp. 602-8.
    Hasenfuss G, Hermann HP, Pieske B. [Dyspnea and normal systolic function]. Herz. 2004;29(6):602-8.
    Hasenfuss, G., Hermann, H. P., & Pieske, B. (2004). [Dyspnea and normal systolic function]. Herz, 29(6), pp. 602-8.
    Hasenfuss G, Hermann HP, Pieske B. [Dyspnea and Normal Systolic Function]. Herz. 2004;29(6):602-8. PubMed PMID: 15912435.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - [Dyspnea and normal systolic function]. AU - Hasenfuss,Gerd, AU - Hermann,Hans-Peter, AU - Pieske,Burkert, PY - 2005/5/25/pubmed PY - 2005/9/9/medline PY - 2005/5/25/entrez SP - 602 EP - 8 JF - Herz JO - Herz VL - 29 IS - 6 N2 - 30-50% of patients presenting with symptoms of congestive heart failure exhibit a near normal left ventricular systolic function at rest, and an impaired diastolic function of the heart may be causative. Despite a better prognosis than in systolic heart failure, frequency of hospitalizations due to diastolic heart failure is comparable with systolic heart failure. According to the criteria of Vasan and Levy diagnosis of diastolic heart failure is probable, if symptoms and signs of heart failure are accompanied in proximity (within 72 h) by objective evidence of normal left ventricular systolic function. Newer echocardiographic techniques (e. g., tissue Doppler) aid to confirm the diagnosis and to determine the severity of dysfunction and may substitute invasive demonstration of impaired left ventricular relaxation, filling, compliance or stiffness for standardized diagnosis. Incorporation of biochemical test (BNP [brain natriuretic peptide]) allows differential diagnosis and may increase the accuracy of diagnosis. Due to inconsistent diagnostic criteria, data from prospective randomized controlled trials for the treatment of diastolic heart failure are rare. Basic principles include treatment of the underlying disease, i. e., control of hypertension, diabetes, or obstructive airway disease. Angiotensin 1 antagonists (ARB) have proven effective in regression of left ventricular hypertrophy (LIFE) and may reduce morbidity, but not mortality (CHARM). Maintenance of sinus rhythm, heart rate control (beta-blockers, calcium channel blockers) and anti-ischemic therapy may be indicated in view of pathophysiological aspects. Diuretics should be administered with caution in patients with symptoms of congestion, digitalis is not useful in the treatment of isolated diastolic heart failure. The results of ongoing trials (e. g., I-Preserve) may offer new therapeutic options, and evidence-based guidelines for the so far often unsatisfactory treatment of diastolic dysfunction/heart failure are awaited. SN - 0340-9937 UR - https://www.unboundmedicine.com/medline/citation/15912435/[Dyspnea_and_normal_systolic_function]_ L2 - http://dx.doi.org/10.1007/s00059-004-2621-1 DB - PRIME DP - Unbound Medicine ER -